Physician profile
Mayur B Kanjia
NPI 1932424751
$46,348.26
in general payments reported to CMS, 2019-2025
50 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,873 · 2020: $2,980 · 2021: $7,669 · 2022: $2,461 · 2023: $7,710 · 2024: $5,804 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $8,648 · Travel and Lodging: $6,081 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,637.50 |
| Food and Beverage | $8,647.58 |
| Travel and Lodging | $6,080.61 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,794.67 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Surgentec | $6,133.42 | 2025 | Tilink, Ion |
| Interventional Pain Technologies INC. | $4,800.00 | 2023 | Vyrsa V1 |
| Stratus Medical, LLC | $3,486.78 | 2021-2025 | Nimbus |
| Medtronic, INC. | $2,965.67 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Abbott Laboratories | $1,633.63 | 2020-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $1,084.48 | 2021-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $549.50 | 2019-2024 | Relistor |
| Nevro Corp. | $429.80 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $344.03 | 2023-2025 | Evoke Scs, Evoke |
| Allergan, INC. | $338.18 | 2019-2022 | |
| Abbvie INC. | $332.81 | 2021-2024 | |
| Painteq LLC | $313.96 | 2023-2024 | Painteq |
| Medtronic USA, INC. | $252.05 | 2019-2020 | |
| Si-Bone, INC. | $244.35 | 2019-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $218.15 | 2024-2025 | Sprint Pns System |
| Spinal Simplicity, LLC | $204.17 | 2023 | Ha Minuteman G3-R |
| Pfizer INC. | $176.48 | 2019 | |
| Vertiflex, INC. | $176.14 | 2019 | |
| Curonix LLC | $171.49 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $170.37 | 2025 | Nalu Neurostimulation System |
| Camber Spine Technologies LLC | $168.29 | 2023 | |
| Arbor Pharmaceuticals, INC. | $155.17 | 2020-2022 | |
| Biodelivery Sciences International, INC. | $147.11 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $136.92 | 2019-2021 | |
| Genesys Orthopedics Systems, L.L.C. | $120.21 | 2025 | Sacroiliac Joint Fusion System |
| Vertos Medical, INC. | $74.62 | 2022-2023 | Mild Device Kit |
| Ferring Pharmaceuticals INC. | $64.29 | 2024-2025 | Euflexxa |
| Linvatec Corporation | $62.11 | 2025 | Biobrace 23mm, Quantum, Neospan |
| Almatica Pharma LLC | $54.72 | 2021 | |
| Mindray Ds USA, INC. | $47.89 | 2024 | Te X, Te7 Max |
| Mdd US Operations, LLC | $47.36 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.58 | 2020-2021 | |
| Axonics, INC. | $34.95 | 2023 | Axonics |
| Kowa Pharmaceuticals America, INC. | $33.62 | 2022 | |
| Globus Medical, INC. | $33.42 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $32.48 | 2019 | |
| Pacira Therapeutics, INC. | $30.88 | 2019 | |
| Lilly USA, LLC | $28.27 | 2023 | Emgality, Reyvow |
| Vertex Pharmaceuticals Incorporated | $27.26 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.44 | 2020 | |
| Bioventus LLC | $22.49 | 2019 | |
| Elutia, INC. | $21.34 | 2020 | |
| Stryker Corporation | $20.75 | 2021 | |
| Masimo Corporation | $20.34 | 2024 | Patient Safetynet System |
| Ibsa Pharma INC. | $19.32 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.51 | 2023 | Belbuca |
| Depuy Synthes Sales INC. | $14.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.99 | 2019 | |
| Assertio Therapeutics, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayur Kanjia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.